PMID- 26551331 OWN - NLM STAT- MEDLINE DCOM- 20160219 LR - 20181113 IS - 1552-5783 (Electronic) IS - 0146-0404 (Print) IS - 0146-0404 (Linking) VI - 56 IP - 12 DP - 2015 Nov TI - Quantitative Fundus Autofluorescence and Optical Coherence Tomography in ABCA4 Carriers. PG - 7274-85 LID - 10.1167/iovs.15-17371 [doi] AB - PURPOSE: To assess whether carriers of ABCA4 mutations have increased RPE lipofuscin levels based on quantitative fundus autofluorescence (qAF) and whether spectral-domain optical coherence tomography (SD-OCT) reveals structural abnormalities in this cohort. METHODS: Seventy-five individuals who are heterozygous for ABCA4 mutations (mean age, 47.3 years; range, 9-82 years) were recruited as family members of affected patients from 46 unrelated families. For comparison, 57 affected family members with biallelic ABCA4 mutations (mean age, 23.4 years; range, 6-67 years) and two noncarrier siblings were also enrolled. Autofluorescence images (30 degrees , 488-nm excitation) were acquired with a confocal scanning laser ophthalmoscope equipped with an internal fluorescent reference. The gray levels (GLs) of each image were calibrated to the reference, zero GL, magnification, and normative optical media density to yield qAF. Horizontal SD-OCT scans through the fovea were obtained and the thicknesses of the outer retinal layers were measured. RESULTS: In 60 of 65 carriers of ABCA4 mutations (age range, 9-60), qAF levels were within normal limits (95% confidence level) observed for healthy noncarrier subjects, while qAF levels of affected family members were significantly increased. Perifoveal fleck-like abnormalities were observed in fundus AF images in four carriers, and corresponding changes were detected in the outer retinal layers in SD-OCT scans. Thicknesses of the outer retinal layers were within the normal range. CONCLUSIONS: With few exceptions, individuals heterozygous for ABCA4 mutations and between the ages of 9 and 60 years do not present with elevated qAF. In a small number of carriers, perifoveal fleck-like changes were visible. FAU - Duncker, Tobias AU - Duncker T AD - Department of Ophthalmology, Columbia University, New York, New York, United States. FAU - Stein, Gregory E AU - Stein GE AD - Department of Ophthalmology, Columbia University, New York, New York, United States. FAU - Lee, Winston AU - Lee W AD - Department of Ophthalmology, Columbia University, New York, New York, United States. FAU - Tsang, Stephen H AU - Tsang SH AD - Department of Ophthalmology, Columbia University, New York, New York, United States 2Department of Pathology and Cell Biology, Columbia University, New York, New York, United States. FAU - Zernant, Jana AU - Zernant J AD - Department of Ophthalmology, Columbia University, New York, New York, United States. FAU - Bearelly, Srilaxmi AU - Bearelly S AD - Department of Ophthalmology, Columbia University, New York, New York, United States. FAU - Hood, Donald C AU - Hood DC AD - Department of Ophthalmology, Columbia University, New York, New York, United States 3Department of Psychology, Columbia University, New York, New York, United States. FAU - Greenstein, Vivienne C AU - Greenstein VC AD - Department of Ophthalmology, Columbia University, New York, New York, United States. FAU - Delori, Francois C AU - Delori FC AD - Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States. FAU - Allikmets, Rando AU - Allikmets R AD - Department of Ophthalmology, Columbia University, New York, New York, United States 2Department of Pathology and Cell Biology, Columbia University, New York, New York, United States. FAU - Sparrow, Janet R AU - Sparrow JR AD - Department of Ophthalmology, Columbia University, New York, New York, United States 2Department of Pathology and Cell Biology, Columbia University, New York, New York, United States. LA - eng GR - R01 EY024091/EY/NEI NIH HHS/United States GR - EY024091/EY/NEI NIH HHS/United States GR - P30 EY019007/EY/NEI NIH HHS/United States GR - EY019007/EY/NEI NIH HHS/United States GR - EY021163/EY/NEI NIH HHS/United States GR - R01 EY021163/EY/NEI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Invest Ophthalmol Vis Sci JT - Investigative ophthalmology & visual science JID - 7703701 RN - 0 (ABCA4 protein, human) RN - 0 (ATP-Binding Cassette Transporters) RN - 9007-49-2 (DNA) SB - IM MH - ATP-Binding Cassette Transporters/*genetics/metabolism MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Child MH - Child, Preschool MH - DNA/*genetics MH - DNA Mutational Analysis MH - Female MH - Fluorescein Angiography/*methods MH - Fundus Oculi MH - Humans MH - Macular Degeneration/*genetics/metabolism/pathology MH - Male MH - Middle Aged MH - *Mutation MH - Retinal Pigment Epithelium/metabolism/*pathology MH - Rod Cell Outer Segment MH - Tomography, Optical Coherence/*methods MH - Young Adult PMC - PMC4642605 EDAT- 2015/11/10 06:00 MHDA- 2016/02/20 06:00 PMCR- 2016/05/01 CRDT- 2015/11/10 06:00 PHST- 2015/11/10 06:00 [entrez] PHST- 2015/11/10 06:00 [pubmed] PHST- 2016/02/20 06:00 [medline] PHST- 2016/05/01 00:00 [pmc-release] AID - 2469813 [pii] AID - IOVS-15-17371 [pii] AID - 10.1167/iovs.15-17371 [doi] PST - ppublish SO - Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7274-85. doi: 10.1167/iovs.15-17371.